Clinical trial
A Postauthorization Safety Surveillance Study Of Xyntha In Usual Care Settings
NCT00765726 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Postauthorization Safety Surveillance Study Of Xyntha In Usual Care Settings
- Lead sponsor
- Pfizer
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 28, 2009
- Completion date
- August 31, 2011
- Enrollment
- 12 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.